Facephi Biometria (XMAD:FACE) Cyclically Adjusted Revenue per Share: €0.85 (As of Dec. 2025)


XMAD:FACE Facephi Biometria SA XMAD:FACE
75 GF Score
Price €1.82
GF Value €2.93
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Facephi Biometria Cyclically Adjusted Revenue per Share?

Facephi Biometria XMAD:FACE -2.15% 75 Cyclically Adjusted Revenue per Share is €0.85 as of Dec. 2025. GuruFocus rates XMAD:FACE with a GF Score™ of 75/100 and a GF Value™ of €2.93 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Facephi Biometria's adjusted revenue per share data for the fiscal year that ended in Dec. 2025 was €1.361. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.85 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Facephi Biometria's average Cyclically Adjusted Revenue Growth Rate was 23.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 25.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Facephi Biometria was 25.50% per year. The lowest was 25.50% per year. And the median was 25.50% per year.

As of today (2026-07-06), Facephi Biometria's current stock price is € 1.82. Facephi Biometria's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec. 2025 was €0.85. Facephi Biometria's Cyclically Adjusted PS Ratio of today is 2.14.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Facephi Biometria was 8.12. The lowest was 2.19. And the median was 3.55.


Facephi Biometria  (XMAD:FACE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Facephi Biometria's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.82/0.85
=2.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Facephi Biometria was 8.12. The lowest was 2.19. And the median was 3.55.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Facephi Biometria Cyclically Adjusted Revenue per Share Related Terms


Facephi Biometria Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Facephi Biometria's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Facephi Biometria Cyclically Adjusted Revenue per Share Chart

Facephi Biometria Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.43 0.56 0.69 0.85

Facephi Biometria Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.00 0.69 0.00 0.85

XMAD:FACE vs UBER, SHOP, CRM: Cyclically Adjusted Revenue per Share Comparison

For the Software - Application subindustry, Facephi Biometria's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Facephi Biometria Cyclically Adjusted PS Ratio vs Software Industry

For the Software industry and Technology sector, Facephi Biometria's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Facephi Biometria's Cyclically Adjusted PS Ratio falls into.


XMAD:FACE
75GF Score
Facephi Biometria SA XMAD:FACE
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Facephi Biometria Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Facephi Biometria's adjusted Revenue per Share data for the fiscal year that ended in Dec. 2025 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=1.361/128.4000*128.4000
=1.361

Current CPI (Dec. 2025) = 128.4000.

Facephi Biometria Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 0.153 101.842 0.193
201712 0.206 102.975 0.257
201812 0.342 104.193 0.421
201912 0.610 105.015 0.746
202012 0.506 104.456 0.622
202112 0.876 111.298 1.011
202212 1.290 117.650 1.408
202312 1.190 121.300 1.260
202412 1.145 124.753 1.178
202512 1.361 128.400 1.361

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.85 mean?
Facephi Biometria (XMAD:FACE) has a Cyclically Adjusted Revenue per Share of €0.85 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Facephi Biometria and its competitors.
Is Facephi Biometria's Cyclically Adjusted Revenue per Share too high?
Facephi Biometria's current Cyclically Adjusted Revenue per Share is €0.85. Overall, Facephi Biometria has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Facephi Biometria's Cyclically Adjusted Revenue per Share compare to UBER and SHOP?
Facephi Biometria's Cyclically Adjusted Revenue per Share of €0.85 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Software company?
A good Cyclically Adjusted Revenue per Share depends on the Software industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Facephi Biometria and its competitors. Facephi Biometria's current Cyclically Adjusted Revenue per Share is €0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Facephi Biometria stock overvalued right now?
Based on GuruFocus' analysis, Facephi Biometria (XMAD:FACE) is currently considered Possible Value Trap. The stock's GF Value™ is €2.93, compared to a current price of €1.82 — trading 37.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.85. Facephi Biometria's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Facephi Biometria (XMAD:FACE), the current Cyclically Adjusted Revenue per Share is €0.85 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Facephi Biometria (XMAD:FACE) Overvalued in 2026?

Based on GuruFocus' analysis, Facephi Biometria stock appears to be undervalued. The current stock price of €1.82 is trading 37.9% below its estimated GF Value™ of €2.93. GuruFocus considers Facephi Biometria to be Possible Value Trap.

Key valuation signals for XMAD:FACE:

  • Cyclically Adjusted Revenue per Share: €0.85
  • GF Value™: €2.93 vs. price of €1.82 (37.9% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the XMAD:FACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Facephi Biometria Business Description

Other Exchanges ALPHI:France8FB:Germany
Address Avenida Perfecto Palacio de la Fuente, 6, Alicante, ESP, 03001
Facephi Biometria SA is a technology company specializing in digital identity verification, fraud prevention, and regulatory compliance solutions. It delivers an AI/ML-powered Identity & Anti-Fraud platform that provides a comprehensive 360-degree end-to-end approach to digital protection. It develops solutions that make digital processes safer, more accessible, and fraud-free. Its technologies help prevent identity theft while ensuring the ethical management and protection of personal data. Geographically, it operates in Spain and the rest of Countries with the majority of the revenue from the rest of Countries.
75GF Score

Get the complete analysis for XMAD:FACE

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.82
Price
€2.93
GF Value